Rocket Pharmaceuticals, Inc.
NASDAQ:RCKT
8.8 (USD) • At close March 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 163.635 | 55.904 | 140.517 | 232.694 | 297.098 | 185.383 | 111.355 | 78.72 | 29.798 | 80.042 | 3.618 | 12.793 | 1.372 |
| Short Term Investments
| 208.701 | 317.271 | 215.877 | 156.046 | 185.621 | 118.732 | 94.375 | 21.294 | 96.675 | 31.238 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 372.336 | 373.175 | 356.394 | 388.74 | 482.719 | 304.115 | 205.73 | 100.014 | 126.473 | 111.28 | 3.618 | 12.793 | 1.372 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 5.847 | 5.047 | 7.666 | 6.638 | 9.252 | 7.278 | 6.716 | 1.033 | 1.876 | 2.172 | 0.104 | 0.066 | 0.045 |
| Total Current Assets
| 378.183 | 378.222 | 364.06 | 392.059 | 487.345 | 307.754 | 209.088 | 101.047 | 128.349 | 112.366 | 3.618 | 12.859 | 1.417 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 83.322 | 87.59 | 77.645 | 72.348 | 70.641 | 31.346 | 2.027 | 0.563 | 1.13 | 0.812 | 0 | 0 | 0 |
| Goodwill
| 39.154 | 39.154 | 39.154 | 30.815 | 30.815 | 30.815 | 30.815 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 25.15 | 25.15 | 25.724 | 0 | 0 | 0.226 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 64.304 | 64.304 | 64.878 | 30.815 | 30.815 | 31.041 | 30.815 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 34.32 | 43.276 | 1.343 | 1.568 | 1.525 | 7.402 | 0.207 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | -1.343 | -1.568 | -1.525 | 0.545 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.891 | 1.905 | 1.948 | 1.798 | 2.023 | 1.98 | 1.436 | -0.039 | 0.168 | 0.143 | 1.902 | 0.004 | 0.004 |
| Total Non-Current Assets
| 149.517 | 188.119 | 187.747 | 104.961 | 103.479 | 64.367 | 42.225 | 0.731 | 1.298 | 0.955 | 1.902 | 0.004 | 0.004 |
| Total Assets
| 527.7 | 566.341 | 551.807 | 497.02 | 590.824 | 372.121 | 251.313 | 101.778 | 129.647 | 113.321 | 5.52 | 12.863 | 1.421 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.451 | 1.592 | 1.633 | 1.146 | 0.229 | 0.387 |
| Short Term Debt
| 2.857 | 2.716 | 5.018 | 5.104 | 9.415 | 1.914 | 0 | 0 | 0 | 0 | 5.084 | 0.693 | 2.208 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | -36.66 | -0 | 0.59 | 0.562 | 0.534 | 0.506 | 0.478 | 0.45 | 0.421 | 0.394 | 0.367 |
| Other Current Liabilities
| 37.827 | 45.789 | 34.151 | 17.063 | 23.202 | 16.395 | 15.372 | 3.113 | 5.62 | 2.508 | -2.527 | 1.185 | 0.298 |
| Total Current Liabilities
| 40.684 | 48.505 | 39.169 | 22.167 | 32.617 | 18.309 | 15.372 | 4.07 | 7.212 | 4.141 | 3.703 | 3.218 | 3.765 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 22.641 | 22.326 | 40.714 | 40.098 | 74.038 | 47.935 | 41.447 | 49.541 | 48.96 | 0 | 2.55 | 5.395 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 1.141 | 2.936 | -17.762 | -19.969 | -19.35 | -1.42 | 0.457 | 0.403 | 0.307 | 0.367 | 50.826 | 43.145 | 28.586 |
| Total Non-Current Liabilities
| 23.782 | 25.262 | 22.952 | 20.129 | 54.688 | 46.515 | 41.904 | 49.944 | 49.267 | 0.367 | 53.376 | 48.54 | 28.586 |
| Total Liabilities
| 64.466 | 73.767 | 62.121 | 42.296 | 87.305 | 64.824 | 57.276 | 54.014 | 56.479 | 4.508 | 57.079 | 51.758 | 32.351 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41.466 | 0.016 | 113.321 | 46.801 | 41.233 | 28.562 |
| Common Stock
| 1.065 | 0.903 | 0.791 | 0.645 | 0.61 | 0.548 | 0.452 | 0.068 | 0.27 | 0.264 | 0.01 | 0.01 | 0.01 |
| Retained Earnings
| -1,218.116 | -959.37 | -713.775 | -491.912 | -322.843 | -183.143 | -105.873 | -268.374 | -238.877 | -196.023 | -128.041 | -118.51 | -110.894 |
| Accumulated Other Comprehensive Income/Loss
| 0.066 | 0.319 | -0.357 | -0.161 | -0.042 | 0.02 | -0.127 | -0.016 | -0.054 | -0.011 | -0.217 | -0.217 | -0.217 |
| Other Total Stockholders Equity
| 1,680.219 | 1,450.722 | 1,203.027 | 946.152 | 825.794 | 489.872 | 299.585 | 538.56 | 311.829 | 304.583 | 123.49 | 79.822 | 80.171 |
| Total Shareholders Equity
| 463.234 | 492.574 | 489.686 | 454.724 | 503.519 | 307.297 | 194.037 | 47.764 | 73.168 | 108.813 | -51.559 | -38.895 | -30.93 |
| Total Equity
| 463.234 | 492.574 | 489.686 | 454.724 | 503.519 | 307.297 | 194.037 | 47.764 | 73.168 | 108.813 | -51.559 | -38.895 | -30.93 |
| Total Liabilities & Shareholders Equity
| 527.7 | 566.341 | 551.807 | 497.02 | 590.824 | 372.121 | 251.313 | 101.778 | 129.647 | 113.321 | 5.52 | 12.863 | 1.421 |